Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Ever After Foods

Ever After Foods aims to develop cultivated meats for the mass market with its patented bioreactor platform
2022
Nov-50
11-50
Haifa, Hefa, Israel

Innovation

Industry Problem

Cultivated meat needs cost-efficient methods to expand large numbers of cells while maintaining quality and reducing bioreactor complexity.

R&D Focus

Three-dimensional cell expansion for cultivated beef and poultry.

Innovative Solution

Uses a patented 3D cell-expansion environment developed from Pluri’s cell-manufacturing technology to grow animal cells at high density.

Investment Funding

Last Funding Stage

Venture - Series Unknown

Total Funding Amount

10.M

Last Funding Amount

10.M

Last Funding Date

18-06-2024

Lead Investors

Pluri, Tnuva

About

Founded in 2022, Ever After Foods is a spin-off from Pluri Inc and is backed by the Tnuva Group. Ever After has developed a patented bioreactor platform which it claims to be highly scalable and cost effective. The company plans on starting with premium meats and later transitioning to more consumed meat options.

Products

Product

Cultivated beef and poultry products enabled by a 3D cell-expansion platform.

Star Product

3D cell-expansion platform – the central scale-up technology behind the cultivated-meat pipeline.

Demo Product or Complete Product?

Precommercial technology and product-development stage.

Future Plan

Market Expansion

Plans to begin with premium meat products before expanding toward more common meat categories.

M&A and Collabs

Collab

Pluri – parent/company-formation partner providing the underlying cell-expansion platform.

Collab

Tnuva Group – strategic partner in the cultivated-meat venture and commercialization effort.

Something missing or incorrect on this page? Help us enrich this information